{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:57:59Z","timestamp":1761631079515,"version":"3.41.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1038\/s41366-025-01716-6","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T03:33:11Z","timestamp":1737862391000},"page":"888-895","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cachectic biomarkers as confounders behind the obesity paradox in patients with acute decompensated heart failure"],"prefix":"10.1038","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5719-2213","authenticated-orcid":false,"given":"Yusuke","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7914-8256","authenticated-orcid":false,"given":"Satoshi","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunobu","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nagatomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Kawakubo Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoko","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"West Tokyo Heart Failure (WET-HF) Registry Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,26]]},"reference":[{"key":"1716_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev. 2017;3:7\u201311.","journal-title":"Card Fail Rev"},{"key":"1716_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","volume":"347","author":"S Kenchaiah","year":"2002","unstructured":"Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305\u201313.","journal-title":"N Engl J Med"},{"key":"1716_CR3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","volume":"38","author":"TB Horwich","year":"2001","unstructured":"Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol. 2001;38:789\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"1716_CR4","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacc.2013.09.072","volume":"63","author":"R Shah","year":"2014","unstructured":"Shah R, Gayat E, Januzzi JL Jr, Sato N, Cohen-Solal A, diSomma S, et al. Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol. 2014;63:778\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"1716_CR5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pcad.2018.05.005","volume":"61","author":"TB Horwich","year":"2018","unstructured":"Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151\u20136.","journal-title":"Prog Cardiovasc Dis"},{"key":"1716_CR6","doi-asserted-by":"crossref","unstructured":"WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157\u201363.","DOI":"10.1016\/S0140-6736(03)15268-3"},{"key":"1716_CR7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73640-w","volume":"10","author":"Y Seko","year":"2020","unstructured":"Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, et al. Association between body mass index and prognosis of patients hospitalized with heart failure. Sci Rep. 2020;10:16663.","journal-title":"Sci Rep"},{"key":"1716_CR8","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/heartjnl-2023-322459","volume":"109","author":"NR Jones","year":"2023","unstructured":"Jones NR, Ord\u00f3\u00f1ez-Mena JM, Roalfe AK, Taylor KS, Goyder CR, Hobbs FR, et al. Body mass index and survival in people with heart failure. Heart. 2023;109:1542\u20139.","journal-title":"Heart."},{"key":"1716_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40170-024-00332-8","volume":"12","author":"GT Ruan","year":"2024","unstructured":"Ruan GT, Deng L, Xie HL, Shi JY, Liu XY, Zheng X, et al. Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexia. Cancer Metab. 2024;12:3.","journal-title":"Cancer Metab"},{"key":"1716_CR10","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1378\/chest.123.5.1460","volume":"123","author":"E Chailleux","year":"2003","unstructured":"Chailleux E, Laaban JP, Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2003;123:1460\u20136.","journal-title":"Chest."},{"key":"1716_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjcard.2022.10.017","volume":"186","author":"MA Mohamad Alahmad","year":"2023","unstructured":"Mohamad Alahmad MA, Acharya P, Gibson CA, Wiley M, Hockstad E, Gupta K. Cachexia is associated with adverse outcomes in patients admitted with heart failure. Am J Cardiol. 2023;186:30\u20135.","journal-title":"Am J Cardiol"},{"key":"1716_CR12","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argil\u00e9s J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clinical Nutrition. 2008;27:793\u20139.","journal-title":"Clinical Nutrition"},{"key":"1716_CR13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/heartjnl-2015-307787","volume":"102","author":"C Franssen","year":"2016","unstructured":"Franssen C, Chen S, Hamdani N, Paulus WJ. From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress. Heart. 2016;102:320\u201330.","journal-title":"Heart."},{"key":"1716_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2015.10.008","volume":"171","author":"Y Shiraishi","year":"2016","unstructured":"Shiraishi Y, Kohsaka S, Abe T, Mizuno A, Goda A, Izumi Y, et al. Validation of the get with the guideline-heart failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level. Am Heart J. 2016;171:33\u20139.","journal-title":"Am Heart J"},{"key":"1716_CR15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","volume":"88","author":"KK Ho","year":"1993","unstructured":"Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation. 1993;88:107\u201315.","journal-title":"Circulation."},{"key":"1716_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1253\/circj.66.987","volume":"66","author":"The Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity.","year":"2002","unstructured":"The Examination Committee of Criteria for \u2018Obesity Disease\u2019 in Japan, Japan Society for the Study of Obesity. New criteria for \u2018obesity disease\u2019 in Japan. Circ J. 2002;66:987\u201392.","journal-title":"Circ J"},{"key":"1716_CR17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/diacare.25.7.1252","volume":"25","author":"T Ota","year":"2002","unstructured":"Ota T, Takamura T, Hirai N, Kobayashi K. Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese. Diabetes Care. 2002;25:1252\u20133.","journal-title":"Diabetes Care"},{"key":"1716_CR18","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/pgmj.2005.037564","volume":"82","author":"M Hickson","year":"2006","unstructured":"Hickson M. Malnutrition and ageing. Postgrad Med J. 2006;82:2\u20138.","journal-title":"Postgrad Med J."},{"key":"1716_CR19","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.3390\/jcm10194378","volume":"10","author":"S Higuchi","year":"2021","unstructured":"Higuchi S, Kohno T, Kohsaka S, Shiraishi Y, Takei M, Goda A, et al. Different impact of beta-blockers on long-term mortality in heart failure patients with and without chronic obstructive pulmonary disease. J Clin Med. 2021;10:4378.","journal-title":"J Clin Med"},{"key":"1716_CR20","first-page":"26","volume":"17","author":"Y Sato","year":"2020","unstructured":"Sato Y, Yoshihisa A, Kimishima Y, Yokokawa T, Abe S, Shimizu T, et al. Prognostic factors in heart failure patients with cardiac cachexia. J Geriatr Cardiol. 2020;17:26\u201334.","journal-title":"J Geriatr Cardiol"},{"key":"1716_CR21","doi-asserted-by":"crossref","unstructured":"Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, et al. 2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol. 2015;66:403\u201369.","DOI":"10.1161\/CIR.0000000000000156"},{"key":"1716_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1716_CR23","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults. Lancet. 2017;390:2627\u201342."},{"key":"1716_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s41999-023-00855-1","volume":"15","author":"S Higuchi","year":"2024","unstructured":"Higuchi S, Matsumoto H, Masaki R, Hirano T, Fuse S, Tanisawa H, et al. Potential confounders of the obesity paradox in older patients following transcatheter aortic valve replacement. Eur Geriatr Med. 2024;15:179\u201387.","journal-title":"Eur Geriatr Med"},{"key":"1716_CR25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00011-022-01586-y","volume":"71","author":"R Nogueira-Ferreira","year":"2022","unstructured":"Nogueira-Ferreira R, Sousa-Nunes F, Leite-Moreira A, Moreira-Costa L, Vitorino R, Lara Santos L, et al. Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators? Inflamm Res. 2022;71:771\u201383.","journal-title":"Inflamm Res"},{"key":"1716_CR26","doi-asserted-by":"crossref","first-page":"586240","DOI":"10.3389\/fcvm.2021.586240","volume":"8","author":"LF Ye","year":"2021","unstructured":"Ye LF, Li XL, Wang SM, Wang YF, Zheng YR, Wang LH. Body mass index: an effective predictor of ejection fraction improvement in heart failure. Front Cardiovasc Med. 2021;8:586240.","journal-title":"Front Cardiovasc Med"},{"key":"1716_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jcsm.13393","volume":"15","author":"AJS Coats","year":"2024","unstructured":"Coats AJS, Butler J, Tsutsui H, Doehner W, Filippatos G, Ferreira JP, et al. Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved. J Cachexia Sarcopenia Muscle. 2024;15:412\u201324.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1716_CR28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/ejhf.2308","volume":"23","author":"C Adamson","year":"2021","unstructured":"Adamson C, Jhund PS, Docherty KF, B\u011blohl\u00e1vek J, Chiang CE, Diez M, et al. Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index. Eur J Heart Fail. 2021;23:1662\u201372.","journal-title":"Eur J Heart Fail"},{"key":"1716_CR29","doi-asserted-by":"crossref","first-page":"afad254","DOI":"10.1093\/ageing\/afad254","volume":"53","author":"R Aldafas","year":"2024","unstructured":"Aldafas R, Crabtree T, Alkharaiji M, Vinogradova Y, Idris I. Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis. Age Ageing. 2024;53:afad254.","journal-title":"Age Ageing"},{"key":"1716_CR30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13098-023-01085-y","volume":"15","author":"X Wang","year":"2023","unstructured":"Wang X, Wu N, Sun C, Jin D, Lu H. Effects of SGLT-2 inhibitors on adipose tissue distribution in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2023;15:113.","journal-title":"Diabetol Metab Syndr"},{"key":"1716_CR31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/s41366-024-01584-6","volume":"48","author":"Z Ruppert","year":"2024","unstructured":"Ruppert Z, Neuperger P, R\u00e1k\u00f3czi B, G\u00e9mes N, Dukay B, Hajdu P, et al. Characterization of obesity-related diseases and inflammation using single cell immunophenotyping in two different diet-induced obesity models. Int J Obes. 2024;48:1568\u201376.","journal-title":"Int J Obes"},{"key":"1716_CR32","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s13300-023-01481-7","volume":"14","author":"S Jahangiri","year":"2023","unstructured":"Jahangiri S, Malek M, Kalra S, Khamseh ME. The effects of sodium-glucose cotransporter 2 inhibitors on body composition in type 2 diabetes mellitus: a narrative review. Diabetes Ther. 2023;14:2015\u201330.","journal-title":"Diabetes Ther"},{"key":"1716_CR33","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","volume":"389","author":"MN Kosiborod","year":"2023","unstructured":"Kosiborod MN, Abildstr\u00f8m SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, et al. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389:1069\u201384.","journal-title":"N Engl J Med"},{"key":"1716_CR34","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","volume":"390","author":"MN Kosiborod","year":"2024","unstructured":"Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, et al. Semaglutide in patients with obesity-related heart failure and Type 2 Diabetes. N Engl J Med. 2024;390:1394\u2013407.","journal-title":"N Engl J Med"},{"key":"1716_CR35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.jacc.2022.02.025","volume":"79","author":"E Driggin","year":"2022","unstructured":"Driggin E, Cohen LP, Gallagher D, Karmally W, Maddox T, Hummel SL, et al. Nutrition assessment and dietary interventions in heart failure: JACC review topic of the week. J Am Coll Cardiol. 2022;79:1623\u201335.","journal-title":"J Am Coll Cardiol"},{"key":"1716_CR36","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009;361:2436\u201348.","journal-title":"N Engl J Med"},{"key":"1716_CR37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","volume":"368","author":"K Swedberg","year":"2013","unstructured":"Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013;368:1210\u20139.","journal-title":"N Engl J Med"},{"key":"1716_CR38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijcard.2020.09.028","volume":"324","author":"S Higuchi","year":"2021","unstructured":"Higuchi S, Hata N, Shibata S, Hirabuki K, Suda T, Honda K, et al. Clinical impact of red blood cell transfusion on adverse clinical events in acute heart failure patients with anemia. Int J Cardiol. 2021;324:102\u20137.","journal-title":"Int J Cardiol"},{"key":"1716_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12872-024-03802-5","volume":"24","author":"P Kosum","year":"2024","unstructured":"Kosum P, Siranart N, Mattanapojanat N, Phutinart S, Kongruttanachok N, Sinphurmsukskul S, et al. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome. BMC Cardiovasc Disord. 2024;24:151.","journal-title":"BMC Cardiovasc Disord"},{"key":"1716_CR40","doi-asserted-by":"crossref","first-page":"e023667","DOI":"10.1161\/JAHA.121.023667","volume":"11","author":"C Held","year":"2022","unstructured":"Held C, Hadziosmanovic N, Aylward PE, Hagstr\u00f6m E, Hochman JS, Stewart RAH, et al. Body mass index and association with cardiovascular outcomes in patients with stable coronary heart disease - a stability substudy. J Am Heart Assoc. 2022;11:e023667.","journal-title":"J Am Heart Assoc"},{"key":"1716_CR41","unstructured":"https:\/\/timi.org\/garden-timi-74\/ (As of 31\/October\/2024)"},{"key":"1716_CR42","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1253\/circj.CJ-16-1087","volume":"80","author":"A Goda","year":"2016","unstructured":"Goda A, Masuyama T. Obesity and overweight in Asian people. Circulation Journal. 2016;80:2425\u20136.","journal-title":"Circulation Journal"},{"key":"1716_CR43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.ijo.0800741","volume":"22","author":"P Deurenberg","year":"1998","unstructured":"Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord. 1998;22:1164\u201371.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"1716_CR44","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ejhf.1244","volume":"20","author":"KW Streng","year":"2018","unstructured":"Streng KW, Voors AA, Hillege HL, Anker SD, Cleland JG, Dickstein K, et al. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018;20:1269\u201377.","journal-title":"Eur J Heart Fail"},{"key":"1716_CR45","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.3390\/jcm11247358","volume":"11","author":"Y Miura","year":"2022","unstructured":"Miura Y, Higuchi S, Kohno T, Shiraishi Y, Kitamura M, Nagatomo Y, et al. Association of potassium level at discharge with long-term mortality in hospitalized patients with heart failure. J Clin Med. 2022;11:7358.","journal-title":"J Clin Med"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01716-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T10:10:22Z","timestamp":1747822222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-025-01716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1716"],"URL":"https:\/\/doi.org\/10.1038\/s41366-025-01716-6","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"type":"print","value":"0307-0565"},{"type":"electronic","value":"1476-5497"}],"subject":[],"published":{"date-parts":[[2025,1,26]]},"assertion":[{"value":"12 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Shiraishi has received lecture fees from Otsuka Pharma-ceuticals Co., Ltd. and Ono Pharmaceuticals Co., Ltd. S. Nakano reports speaking fees and consulting fees from Pfizer and Otsuka. S. Kohsaka reports an investigator-initiated grant from Novartis, and personal fees from Bristol-Myers Squibb. All other authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}